|
|
Volumn 7, Issue , 2009, Pages
|
|
Summary of the primer on tumor immunology and the biological therapy of cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANGIOGENESIS INHIBITOR;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
BORTEZOMIB;
CANCER VACCINE;
CYCLOPHOSPHAMIDE;
CYTOKINE;
CYTOKINE ANTIBODY;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY;
DNA VACCINE;
DOXORUBICIN;
HISTONE DEACETYLASE INHIBITOR;
IMMUNOLOGICAL ADJUVANT;
INTERLEUKIN 15;
INTERLEUKIN 2;
INTERLEUKIN 21;
IPILIMUMAB;
MONOCLONAL ANTIBODY;
PEPTIDE VACCINE;
TUMOR ANTIGEN;
TUMOR NECROSIS FACTOR ALPHA;
ADOPTIVE IMMUNOTHERAPY;
ANTINEOPLASTIC ACTIVITY;
CANCER ADJUVANT THERAPY;
CANCER IMMUNOLOGY;
CANCER IMMUNOTHERAPY;
CANCER STAGING;
CELL THERAPY;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
DRUG CYTOTOXICITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG MEGADOSE;
DRUG RESEARCH;
DRUG RESPONSE;
DRUG SAFETY;
DRUG SYNTHESIS;
DRUG TARGETING;
EDITORIAL;
HODGKIN DISEASE;
HUMAN;
IMMUNOLOGICAL MONITORING;
KIDNEY CANCER;
KIDNEY CARCINOMA;
MALIGNANT NEOPLASTIC DISEASE;
MELANOMA;
NONHUMAN;
OVARY CANCER;
PROSTATE CANCER;
REGULATORY T LYMPHOCYTE;
T LYMPHOCYTE;
TUMOR VASCULARIZATION;
UNSPECIFIED SIDE EFFECT;
VACCINE PRODUCTION;
ARTICLE;
BIOLOGICAL THERAPY;
CELL SURVIVAL;
IMMUNOLOGY;
IMMUNOTHERAPY;
NEOPLASM;
PATHOLOGY;
VASCULARIZATION;
ADJUVANTS, IMMUNOLOGIC;
ANGIOGENESIS INHIBITORS;
ANTIGENS, NEOPLASM;
BIOLOGICAL THERAPY;
CELL SURVIVAL;
CYTOKINES;
HUMANS;
IMMUNOTHERAPY;
NEOPLASM STAGING;
NEOPLASMS;
T-LYMPHOCYTES;
|
|
EID: 61849140721
PISSN: None
EISSN: 14795876
Source Type: Journal
DOI: 10.1186/1479-5876-7-11 Document Type: Editorial |
|
Times cited : (11)
|
|
References (0)
|
